Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 03 2025
0mins
Source: Globenewswire
HeartSciences Patent Announcement: HeartSciences Inc. has been granted a foundational patent by the USPTO for estimating echocardiography parameters using ECG, enhancing its extensive intellectual property portfolio which now includes 10 US patents and 34 international patents.
Company's Mission and Product Development: The company aims to improve cardiac screening through AI-powered ECG technology, with its first product candidate, MyoVista®, designed to provide diagnostic information traditionally obtained from cardiac imaging, thereby enhancing clinical utility in healthcare settings.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
